Ancuceanu R, Dinu M, Dinu-Pirvu C, Anuţa V, Negulescu V (2019) Pharmacokinetics of b-ring unsubstituted flavones. Pharmaceutics 11:370. https://doi.org/10.3390/pharmaceutics11080370

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balakrishnan M, Rehm J (2024) A public health perspective on mitigating the global burden of chronic liver disease. Hepatology 79:451–459. https://doi.org/10.1097/HEP.0000000000000679

Article  PubMed  Google Scholar 

Bao Y, Ding H, Zhang Z, Yang K, Tran Q, Sun Q, Xu T (2023) Intelligent acupuncture: data-driven revolution of traditional Chinese medicine. Acupunct Herb Med 3:271–284. https://doi.org/10.1097/HM9.0000000000000077

Article  CAS  Google Scholar 

Beretta-Piccoli BT, Mieli-Vergani G, Vergani D (2017) Autoimmune hepatitis: standard treatment and systematic review of alternative treatments. World J Gastroenterol 23:6030. https://doi.org/10.3748/wjg.v23.i33.6030

Article  Google Scholar 

Bergheim I, Moreno-Navarrete JM (2024) The relevance of intestinal barrier dysfunction, antimicrobial proteins and bacterial endotoxin in metabolic dysfunction-associated steatotic liver disease. Eur J Clin Invest 54:e14224. https://doi.org/10.1111/eci.14224

Article  CAS  PubMed  Google Scholar 

Bódis K, Bombrich M, Schön M, Knebel B, Zaharia O-P, Bönhof G, Karusheva Y, Strassburger K, Kupriyanova Y, Kotzka J (2023) Effects of TM6SF2 rs58542926 polymorphism on hepatocellular lipids and insulin resistance in early type 2 diabetes. Nutr Metab Cardiovasc Dis 33:1785–1796. https://doi.org/10.1016/j.numecd.2023.06.004

Article  CAS  PubMed  Google Scholar 

Bourganou MV, Chondrogianni ME, Kyrou I, Flessa C-M, Chatzigeorgiou A, Oikonomou E, Lambadiari V, Randeva HS, Kassi E (2025) Unraveling metabolic dysfunction-associated steatotic liver disease through the use of omics technologies. Int J Mol Sci 26:1589. https://doi.org/10.3390/ijms26041589

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao P, Wang Y, Zhang C, Sullivan MA, Chen W, Jing X, Yu H, Li F, Wang Q, Zhou Z (2023) Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy. J Nutr Biochem 120:109414. https://doi.org/10.1016/j.jnutbio.2023.109414

Article  CAS  PubMed  Google Scholar 

Cheemerla S, Balakrishnan M (2021) Global epidemiology of chronic liver disease. Clin Liver Dis 17:365–370. https://doi.org/10.1002/cld.1061

Article  Google Scholar 

Chen H, He Y, Chen S, Qi S, Shen J (2020a) Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: applications for natural product efficacy with omics and systemic biology. Pharmacol Res 158:104877. https://doi.org/10.1016/j.phrs.2020.104877

Chen J, Hu Y, Chen L, Liu W, Mu Y, Liu P (2019) The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases. Biomed Pharmacother 114:108846. https://doi.org/10.1016/j.biopha.2019.108846

Chen X-M, Zhang S, Gao S-Q, Xu M (2025) Interleukin-6 in epilepsy and its neuropsychiatric comorbidities: how to bridge the gap. World J Psychiatry 15:100297. https://doi.org/10.5498/wjp.v15.i1.100297

Article  PubMed  PubMed Central  Google Scholar 

Chen X, Ma X, Wang R, Wang L, Li J, Liu H, He T, Wei S, Li H, Wang M (2020b) Treatment of primary biliary cirrhosis with ursodeoxycholic acid combined with traditional Chinese medicine: a protocol for systematic review and meta analysis. Medicine (Baltimore) 99:e23107. https://doi.org/10.1097/MD.0000000000023107

Chen Y-S, Wen C-K, Liu G-H, Lee T-Y (2022) Electroacupuncture attenuates vascular hyporeactivity in a rat model of portal hypertension induced by bile duct ligation. Acupunct Med 40:68–77. https://doi.org/10.1177/09645284211039230

Article  PubMed  Google Scholar 

Chen Z, Lin T, Liao X, Li Z, Lin R, Qi X, Chen G, Sun L, Lin L (2021) Network pharmacology based research into the effect and mechanism of Yinchenhao decoction against cholangiocarcinoma. Chin Med 16:13. https://doi.org/10.1186/s13020-021-00423-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui B, Peng F, Lu J, He B, Su Q, Luo H, Deng Z, Jiang T, Su K, Huang Y (2021) Cancer and stress: NextGen strategies. Brain Behav Immun 93:368–383. https://doi.org/10.1016/j.bbi.2020.11.014

Article  CAS  PubMed  Google Scholar 

Di Zeo-Sánchez DE, Segovia-Zafra A, Matilla-Cabello G, Pinazo-Bandera JM, Andrade RJ, Lucena MI, Villanueva-Paz M (2022) Modeling drug-induced liver injury: current status and future prospects. Expert Opin Drug Metab Toxicol 18:555–573. https://doi.org/10.1080/17425255.2022.2038730

Article  PubMed  Google Scholar 

Dikariyanto V, Smith L, Francis L, Robertson M, Kusaslan E, O’Callaghan-Latham M, Palanche C, D’Annibale M, Christodoulou D, Basty N (2020) Snacking on whole almonds for 6 weeks improves endothelial function and lowers LDL cholesterol but does not affect liver fat and other cardiometabolic risk factors in healthy adults: the ATTIS study, a randomized controlled trial. Am J Clin Nutr 111:1178–1189. https://doi.org/10.1093/ajcn/nqz344

Article  PubMed  PubMed Central  Google Scholar 

Du K, Liang C, Chang Y (2024) Network pharmacology to clarify the effective substances and their action mechanisms of traditional Chinese medicines. In: Li S, Zhao J (eds) Quality Control of Chinese Medicines. Springer, Singapore. https://doi.org/10.1007/978-981-99-9871-5_6

Duan W, Zhou L, Ren Y, Liu F, Xue Y, Wang F-Z, Lu R, Zhang X-J, Shi J-S, Xu Z-H (2024) Lactic acid fermentation of goji berries (Lycium barbarum) prevents acute alcohol liver injury and modulates gut microbiota and metabolites in mice. Food Funct 15:1612–1626. https://doi.org/10.1039/D3FO03842E

Article  CAS  PubMed  Google Scholar 

Dubey A, Reddy K, Kishor C, Doss S, Hanafiah MM (2024) Exploring the advancements and future directions of digital twins in Healthcare 6.0. IGI Global. https://doi.org/10.4018/979-8-3693-5893-1

Duguay D, Cermakian N (2009) The crosstalk between physiology and circadian clock proteins. Chronobiol Int 26:1479–1513. https://doi.org/10.3109/07420520903367983

Article  CAS  PubMed  Google Scholar 

Emerald M (2024) Medicinal plants: therapeutic potential, safety, and toxicity. In: Drug discovery and evaluation: safety and pharmacokinetic assays, pp 1327–1397. Springer. https://doi.org/10.1007/978-3-030-73317-9_90-1

Enitan SS, Soboyejo PH, Digban KA, Iduh MU, Asekun-Olarinmoye IO, Azike CA, Itodo GE, Adole AR, Okuneye AO (2024) Advancing toward a hepatitis C-free world: emerging therapies, persistent challenges, and future prospects. Avicenna J Clin Microbiol Infect 11:182–190. https://doi.org/10.34172/ajcmi.3563

Article  CAS  Google Scholar 

Estefes-Duarte JA, Espinosa-Sánchez A, Pérez-Hernández N, Ortiz MI, Fernández-Martínez E (2024) Mechanisms of bioactive lipids to modulate master regulators of lipid homeostasis and inflammation in metabolic syndrome. Curr Pharm Biotechnol. https://doi.org/10.2174/0113892010340506241014112341

Article  Google Scholar 

Fan L (2021) Krüppel-like factor 15 orchestrates systemic metabolic homeostasis. Case Western Reserve University, p 131. https://www.proquest.com/openview/78beb54635fe85d01a357e08bc4a6e4b/1?cbl=18750&diss=y&pq-origsite=gscholar

Fang X, Song J, Zhou K, Zi X, Sun B, Bao H, Li L (2023) Molecular mechanism pathways of natural compounds for the treatment of non-alcoholic fatty liver disease. Molecules 28:5645. https://doi.org/10.3390/molecules28135645

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fontana RJ, Liou I, Reuben A, Suzuki A, Fiel MI, Lee W, Navarro V (2023) Aasld practice guidance on drug, herbal, and dietary supplement–induced liver injury. Hepatology 77:1036–1065. https://doi.org/10.1002/hep.32689

Article  PubMed  Google Scholar 

Fu K, Wang C, Ma C, Zhou H, Li Y (2021) The potential application of Chinese medicine in liver diseases: a new opportunity. Front Pharmacol 12:771459. https://doi.org/10.3389/fphar.2021.771459

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu Y, Wang Z, Qin H (2024) Examining the pathogenesis of MAFLD and the medicinal properties of natural products from a metabolic perspective. Metabolites 14:218. https://doi.org/10.3390/metabo14020218

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ganguly R, Kumar R, Pandey AK (2022) Baicalin provides protection against fluoxetine-induced hepatotoxicity by modulation of oxidative stress and inflammation. World J Hepatol 14(4):729. https://doi.org/10.4254/wjh.v14.i4.729

Article  PubMed  PubMed Central  Google Scholar 

Gao W, Xu B, Zhang Y, Liu S, Duan Z, Chen Y, Zhang X (2022) Baicalin attenuates oxidative stress in a tissue-engineered liver model of NAFLD by scavenging reactive oxygen species. Nutrients 14:541. https://doi.org/10.3390/nu14030541

Article  CAS  PubMed  PubMed Central  Google Scholar 

Govaere O, Cockell S, Tiniakos D, Queen R, Younes R, Vacca M, Alexander L, Ravaioli F, Palmer J, Petta S (2020) Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci Transl Med 12:eaba4448. https://doi.org/10.1126/scitranslmed.aba4448

Article  CAS  PubMed